Vasomotor flushes.
Walsh
B
B
Department of Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts 02115.
Schiff
I
I
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D001533:Belladonna Alkaloids; D003000:Clonidine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004879:Ergotamines / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D005483:Flushing / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D009626:Terminology as Topic; D014666:Vasomotor System / Q000502:physiology*
D000316:Adrenergic alpha-Agonists; D001533:Belladonna Alkaloids; D004338:Drug Combinations; D004879:Ergotamines; D011372:Progestins; C044435:belladonna alkaloid, ergotamine, phenobarbital drug combination; D003000:Clonidine; D008784:Methysergide; D010634:Phenobarbital